Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection

Am J Ther. 2021 Aug 10;28(5):e590-e591. doi: 10.1097/MJT.0000000000001437.

Authors

Swaminathan P Sathyanarayanan¹, Muhammad Hamza¹, Khizar Hamid¹, Dayna Groskreutz²

Affiliations

¹ Department of Internal Medicine.
² Division of Pulmonary/Critical Care, University of South Dakota Sanford School of Medicine, Sioux Falls, SD.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Atracurium / adverse effects*
Atracurium / analogs & derivatives*
Atracurium / therapeutic use
COVID-19 / complications*
Dyspnea
Humans
Male
Malignant Hyperthermia
Middle Aged
Neuromuscular Blocking Agents / adverse effects*
Neuromuscular Blocking Agents / therapeutic use
SARS-CoV-2 / isolation & purification*

Substances

Neuromuscular Blocking Agents
Atracurium
cisatracurium